Hughes-Wilson Alexandra Insider Profile

4 Followers
Hughes-Wilson Alexandra, Chief Patient Access and Commercial Planning at Mereo Biopharma Group Plc, holds 34.55K shares in Mereo Biopharma Group Plc (Ticker: MREO).
tipranks
Hughes-Wilson Alexandra

Hughes-Wilson Alexandra
Mereo Biopharma Group Plc (MREO)
Chief Patient Access and Commercial Planning

Not Ranked
Hughes-Wilson Alexandra has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$144K
100.00%
A breakdown of Hughes-Wilson Alexandra's holdings

Insider Roles

Mereo Biopharma Group Plc
(MREO)
Chief Patient Access and Commercial Planning
Roles that Hughes-Wilson Alexandra holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Hughes-Wilson Alexandra

Hughes-Wilson Alexandra's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mereo Biopharma Group Plc
Jun 27, 2024
Chief Patient Access and Commercial Planning
Uninformative Sell
115.26K
$143.55K
Hughes-Wilson Alexandra has not reported any informative transactions for MREO, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 23, 2024
Uninformative Buy
$0.00
-
$1.75
Jun 25, 2024
Uninformative Buy
$238.80K
-
$3.98
Jun 27, 2024
Uninformative Sell
$115.26K
-
$3.48
List of latest transactions for each holding click on a transaction to see Hughes-Wilson Alexandra's performance on stock

Hughes-Wilson Alexandra insider profile FAQ

What is the percentage of profitable transactions made by Hughes-Wilson Alexandra?
The percentage of profitable transactions made by Hughes-Wilson Alexandra is ―.
    What is the average return per transaction made by Hughes-Wilson Alexandra?
    The average return per transaction made by Hughes-Wilson Alexandra is ―.
      What stocks does Hughes-Wilson Alexandra hold?
      Hughes-Wilson Alexandra holds: MREO stocks.
        What was Hughes-Wilson Alexandra’s latest transaction?
        Hughes-Wilson Alexandra latest transaction was an Uninformative Sell of $115.26K.
          What was Hughes-Wilson Alexandra's most profitable transaction?
          Hughes-Wilson Alexandra’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc?
            Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc is Chief Patient Access and Commercial Planning.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.